St. Jude struggles with its image after Durata concerns

By Damian Garde St. Jude Medical ($STJ) has some ground to make up. After months of alarming news and growing worry over its Durata defibrillator leads, the onus falls on the Minnesota ...

J&J/Ethicon wins FDA nod for biologic blood-clotting patch

By Mark Hollmer Johnson & Johnson’s ($JNJ) Ethicon Biosurgery gained the FDA‘s blessing for a new device designed to stop otherwise-uncontrollable bleeding during ...

Report: Sanofi considering Bayer’s glucose meter unit

By Damian Garde Don’t close the book on Bayer‘s rumored sale of its blood glucose meter business just yet. After sources said the drug giant was halting its offer, The ...

Major Weekend Biotech Announcements Could Produce Gains on Monday

By Brian Nichols The weekend is always the source for many big-time data announcements and presentations in the biotechnology space. The most significant annual meetings are usually ...

Will “Pay for Delay” Ruling Cost Drug Companies?

By James Flaherty The U.S. Supreme Court will review a case involving the drug industry and federal antitrust enforcers that could have multi-billion dollar implications. Bloomberg ...

Biogen Idec and Isis Pharmaceuticals Announce Collaboration For Antisense Programs To Treat Neurological Disorders

–Biogen Idec has Option to Develop and Commercialize Promising Compounds from Three Research Programs to Treat Neurological or Neuromuscular Disorders– –Isis Expands ...

Medtronic Beats on Revenue, Matches Expectations on EPS

By Seth Jayson Medtronic (NYSE: MDT  ) reported earnings on Dec. 5. Here are the numbers you need to know. The 10-second takeaway For the quarter ended Oct. 26 (Q2), Medtronic ...

Merck Wins Reversal In Sales Rep Retaliation Case

 By Ed Silverman A federal appeals court has reversed a $555,000 jury verdict that was awarded early last year to a former Merck sales rep, who claimed she suffered retaliation after ...

Amgen Agrees to Buy DeCode Genetics for $415 Million

By Shannon Pettypiece Amgen Inc. (AMGN), the world’s largest biotechnology company, agreed to buy the genetic-research company DeCode Genetics Inc. for $415 million to help it develop ...

Sarepta Is Still A Buy: Recent Concerns Much Ado About Nothing

By Nathan Sadeghi-Nejad BOSTON (TheStreet) — Sarepta Therapeutics (SRPT_) is a near-perfect microcosm of the promise and pitfalls of biotech. After 22 years in relative obscurity ...

FDA Introduces New Form for Reporting Tobacco Violations

ROCKVILLE, Md. — The U.S. Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) has added another tool to catch tobacco violations. This week, the CTP ...

Medical device tax: Sen. Hagan still searching for a pay-for to foster repeal

By MassDevice staff  Senator Kay Hagan (D-N.C.) is looking to her state’s business leaders to find a way to repeal the 2.3% medical device tax and make up for the make up for ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS